BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Gilead Sciences, Inc.'s Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Maintains High Viral Suppression Through 48 Weeks in Phase 2 Study

  September 13, 2013

   · 

  1 min read
• Policy

  GlycoMimetics, Inc. Announces European Medicines Agency’s Granting of Orphan Drug Status in European Union for GMI-1070 in Sickle Cell Disease

  September 13, 2013

   · 

  1 min read
• Deals

  Hart-Scott-Rodino Waiting Period Expires for Cubist Pharmaceuticals, Inc. Acquisition of Optimer Pharmaceuticals, Inc.

  September 13, 2013

   · 

  1 min read
• FDA

  Alexion Pharmaceuticals Inc.'s Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients With aHUS

  September 13, 2013

   · 

  1 min read
• BioForest

  Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants

  September 13, 2013

   · 

  3 min read
• BioForest

  Cell Therapeutics, Inc. Announces Sale of Convertible Preferred Stock

  September 13, 2013

   · 

  5 min read
• Business

  Creative Biogene Extends Supply Agreement of Retrvirectin Reagents for International Clients

  September 13, 2013

   · 

  1 min read
• BioMidwest

  Nanosphere, Inc. Prices $26.3 Million Public Offering of Common Stock

  September 13, 2013

   · 

  4 min read
• Policy

  Johnson & Johnson Ex-Staffer Claims to be Whistle-Blower in Baby Powder Row

  September 13, 2013

   · 

  1 min read
• Deals

  Abbott Laboratories May Buy Certain Assets of Johnson & Johnson in Pakistan

  September 13, 2013

   · 

  1 min read